Abdera Therapeutics
Gita Dehnad is a seasoned administrative professional with extensive experience in executive support roles across various industries. Currently serving as a Senior Executive Assistant to the President & CEO and CFO at Abdera Therapeutics and a Senior Executive Assistant at a Stealth Biotech Company since early 2023, Gita has previously held senior assistant positions at Identifeye Health and GRAIL, Inc. Notable roles include support for executives at Dermira, Inc., and multiple positions at Stanford University, where Gita progressed from Educational Programs Coordinator to Operations Manager. Additional experience includes roles in mentorship, interior design, and event planning, as well as contributions to various educational initiatives. Gita Dehnad holds a Bachelor of Arts in English Language and Literature from the University of California, Berkeley, and has completed a Certificate in Management Essentials from Harvard Business School Online.
This person is not in any offices
Abdera Therapeutics
1 followers
Abdera is an oncology company developing targeted alpha therapies (TATs) for patients with relapsed, refractory, and metastatic cancers. Its targeted radiotherapies utilize purpose-built vectors to specifically target high-energy radio-isotopes to tumors and metastatic cancer lesions. This new class of drugs holds tremendous untapped therapeuticand commercial potential, and has generated over $10B in recent M&A, financings, and product launches – and are expected to comprise 70% of the $30B nuclear medicine market by 2030.It was launched by adMare BioInnovations, Canada’s global life sciences venture, in partnership with industry leaders AbCellera, and some of the country’s most successful scientist entrepreneurs.